Okada A - Search Results

1

Controlled release of a model hydrophilic high molecular weight compound from injectable non-lamellar liquid crystal formulations containing different types of phospholipids.

Okada A, Todo H, Hijikuro I, Itakura S, Sugibayashi K. Okada A, et al. Int J Pharm. 2020 Mar 15;577:118944. doi: 10.1016/j.ijpharm.2019.118944. Epub 2019 Dec 21. Int J Pharm. 2020. PMID: 31870952

2

Design of a Topically Applied Gel Spray Formulation with Ivermectin Using a Novel Low Molecular Weight Gelling Agent, Palmitoyl-Glycine-Histidine, to Treat Scabies.

Dahlizar S, Futaki M, Okada A, Kadhum WR, Todo H, Sugibayashi K. Dahlizar S, et al. Among authors: okada a. Chem Pharm Bull (Tokyo). 2018;66(3):327-333. doi: 10.1248/cpb.c17-00965. Chem Pharm Bull (Tokyo). 2018. PMID: 29491265 Free article.

3

Combined Use of N-Palmitoyl-Glycine-Histidine Gel and Several Penetration Enhancers on the Skin Permeation and Concentration of Metronidazole.

Dahlizar S, Futaki M, Okada A, Yatomi C, Todo H, Sugibayashi K. Dahlizar S, et al. Among authors: okada a. Pharmaceutics. 2018 Sep 20;10(4):163. doi: 10.3390/pharmaceutics10040163. Pharmaceutics. 2018. PMID: 30241371 Free PMC article.

4

Enhanced nose-to-brain delivery of tranilast using liquid crystal formulations.

See GL, Arce F Jr, Dahlizar S, Okada A, Fadli MFBM, Hijikuro I, Itakura S, Katakura M, Todo H, Sugibayashi K. See GL, et al. Among authors: okada a. J Control Release. 2020 Sep 10;325:1-9. doi: 10.1016/j.jconrel.2020.06.028. Epub 2020 Jun 26. J Control Release. 2020. PMID: 32598958

5

Development of Spray Formulations Applied to the Oral Mucosa Using Non-lamellar Liquid Crystal-Forming Lipids.

Sugibayashi K, Yamamoto N, Itakura S, Okada A, Hijikuro I, Todo H. Sugibayashi K, et al. Among authors: okada a. Chem Pharm Bull (Tokyo). 2020;68(11):1025-1033. doi: 10.1248/cpb.c20-00333. Chem Pharm Bull (Tokyo). 2020. PMID: 33132369 Free article.

6

A Lipid-Based Depot Formulation with a Novel Non-lamellar Liquid Crystal Forming Lipid.

Okada A, Todo H, Itakura S, Hijikuro I, Sugibayashi K. Okada A, et al. Pharm Res. 2021 Mar;38(3):503-513. doi: 10.1007/s11095-021-03014-y. Epub 2021 Feb 26. Pharm Res. 2021. PMID: 33638122 Free PMC article.

7

Improvement of Skin Permeation of Caffeine, a Hydrophilic Drug, by the Application of Water Droplets Provided by a Novel Humidifier Device.

Todo H, Hasegawa Y, Okada A, Itakura S, Sugibayashi K. Todo H, et al. Among authors: okada a. Chem Pharm Bull (Tokyo). 2021;69(8):727-733. doi: 10.1248/cpb.c21-00110. Chem Pharm Bull (Tokyo). 2021. PMID: 34334516 Free article.

8

Development of Self-Administered Formulation to Improve the Bioavailability of Leuprorelin Acetate.

Okada A, Niki R, Inoue Y, Tomita J, Todo H, Itakura S, Sugibayashi K. Okada A, et al. Pharmaceutics. 2022 Apr 3;14(4):785. doi: 10.3390/pharmaceutics14040785. Pharmaceutics. 2022. PMID: 35456619 Free PMC article.

9

Self-Assembled Structure of α-Isostearyl Glyceryl Ether Affects Skin Permeability-a Lamellar with 70-nm Spaces and L3 Phase Enhanced the Transdermal Delivery of a Hydrophilic Model Drug.

Sano T, Okada A, Kawasaki K, Kume T, Fukui M, Todo H, Sugibayashi K. Sano T, et al. Among authors: okada a. AAPS PharmSciTech. 2022 Nov 11;23(8):296. doi: 10.1208/s12249-022-02452-0. AAPS PharmSciTech. 2022. PMID: 36369392

10

Development of an Auraptene-Loaded Transdermal Formulation Using Non-ionic Sugar Ester Surfactants.

Flores KA, Okada A, Arce F Jr, See GL, Itakura S, Todo H, Sugibayashi K. Flores KA, et al. Among authors: okada a. Chem Pharm Bull (Tokyo). 2024;72(3):319-323. doi: 10.1248/cpb.c23-00796. Chem Pharm Bull (Tokyo). 2024. PMID: 38508724 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,033 results

Search Page

Filters